AstraZeneca Q4 Earnings Beat, Sales Hurt By COVID Jab
February 09, 2023 at 08:23 AM EST
Core earnings of $1.38 per share declined 17% year over year on a reported basis and 5% at constant exchange rates (CER).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|